# Neutrophils and aortic medial amyloid: mutually beneficial or a dangerous combination?

**Authors:** Alana Maerivoet, Sarah Shirley, Rebecca Price, David Wilkinson, Helen L. Wright, Jillian Madine

PMC · DOI: 10.3389/fimmu.2026.1699039 · Frontiers in Immunology · 2026-02-06

## TL;DR

This study explores how neutrophils affect medin amyloid formation in the aorta, revealing complex interactions that could influence disease progression.

## Contribution

The study identifies how neutrophil components modulate medin aggregation and toxicity, offering new insights into amyloid-related pathologies.

## Key findings

- Neutrophil supernatants reduce medin fibril formation and cell toxicity.
- Inhibiting MMPs and serine proteases reverses the anti-aggregation effects of neutrophils.
- Cysteine protease inhibition mimics neutrophil effects but increases cell toxicity significantly.

## Abstract

Amyloid deposition and inflammation are associated with many human diseases, with inflammatory cells found co-localised with amyloid in a range of tissues. Medin is the peptide that forms the most common localised amyloid in the aortic medial layer, yet remarkably little is known about its role in disease or factors that modulate its aggregation.

We investigated the effect of neutrophil degranulation supernatants on medin fibril formation in vitro and explored the impact of inhibiting proteolytic components of neutrophil degranulation on aggregation using Thioflavin T fluorescence, transmission electron microscopy and cell viability analyses.

We showed that neutrophil supernatants reduced fibril formation of medin and its associated cell toxicity. Addition of inhibitors targeting MMPs (GM6001) and serine proteases (AEBSF) reversed the effects of neutrophils on fibril formation and cell toxicity. In contrast, inhibiting cysteine proteases using E64 showed comparable low ThT fluorescence and a lack of fibrils similar to what is observed for medin in the presence of neutrophil supernatants alone. However, despite appearing comparable to neutrophils alone, species produced showed significantly increased cell toxicity of up to 60% (P<0.0001).

This data has implications for understanding the role of neutrophil-mediated inflammation in medin-associated pathologies and provides avenues to explore for future therapeutic intervention.

## Linked entities

- **Chemicals:** GM6001 (PubChem CID 132519), AEBSF (PubChem CID 186136), E64 (PubChem CID 123985), Thioflavin T (PubChem CID 16953)

## Full-text entities

- **Genes:** CTSS (cathepsin S) [NCBI Gene 1520], TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CTSK (cathepsin K) [NCBI Gene 1513] {aka CTS02, CTSO, CTSO1, CTSO2, PKND, PYCD}, ADAM8 (ADAM metallopeptidase domain 8) [NCBI Gene 101] {aka CD156, CD156a, MS2}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, CD40 (CD40 molecule) [NCBI Gene 958] {aka Bp50, CDW40, TNFRSF5, p50}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, MFGE8 (milk fat globule EGF and factor V/VIII domain containing) [NCBI Gene 4240] {aka BA46, EDIL1, HMFG, HsT19888, MFG-E8, MFGM}, ELANE (elastase, neutrophil expressed) [NCBI Gene 1991] {aka ELA2, GE, HLE, HNE, NE, PMN-E}
- **Diseases:** AD (MESH:D000544), aneurysm (MESH:D000783), aneurysm and dissection (MESH:D000784), vascular diseases (MESH:D014652), cancer (MESH:D009369), aortic aneurysm (MESH:D001014), Inflammatory (MESH:D007249), psoriasis (MESH:D011565), NETs (MESH:C536657), respiratory (MESH:D012131), cerebral amyloid angiopathy (MESH:D016657), autoimmune diseases (MESH:D001327), cardiovascular diseases (MESH:D002318), cerebrovascular diseases (MESH:D002561), cytotoxic (MESH:D064420), vascular dementia (MESH:D015140), cognitive decline (MESH:D003072), pathologies (MESH:D005598), AMA (MESH:C000718787)
- **Chemicals:** His (MESH:D006639), ammonium chloride (MESH:D000643), PMA (MESH:D013755), GM6001 (MESH:C078131), carbon (MESH:D002244), T (MESH:D014316), NaCl (MESH:D012965), CaCl2 (MESH:D002122), copper (MESH:D003300), SDS (MESH:D012967), nitric oxide (MESH:D009569), E64 (MESH:C024974), CCK-8 (MESH:D012844), water (MESH:D014867), Imidazole (MESH:C029899), lithium (MESH:D008094), ThT (MESH:C009462), Ni2+-NTA (MESH:C088321), Brij35 (MESH:C515901), uranyl acetate (MESH:C005460), 4-(2-aminoethyl)-benzenesulfonyl fluoride (MESH:C002010), superoxide (MESH:D013481), AMA (-), ThT (MESH:C121030), sodium phosphate (MESH:C018279), PBS (MESH:D007854), heparin (MESH:D006493), cytochalasin B (MESH:D003571), DMSO (MESH:D004121), guanidine hydrochloride (MESH:D019791), PEG 6000 (MESH:C000595215), ROS (MESH:D017382), CO2 (MESH:D002245), peroxynitrite (MESH:D030421), IPTG (MESH:D007544), His6 (MESH:C471213)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HUVEC — Homo sapiens (Human), Finite cell line (CVCL_2959), Lemo 21 (DE3) — Mus musculus (Mouse), Hybridoma (CVCL_B7HM)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920188/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12920188/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920188/full.md

---
Source: https://tomesphere.com/paper/PMC12920188